Tag Archives: Medication effects – wanted and unwanted
Adults with depression and who take specific anti-depressants more likely to develop C. difficile
Interesting applied psychoimmunology study. Apparently depressed people’s guts don’t watch direct-to-consumer chemical-imbalance ads. Here is the abstract. Depression, antidepressant medications, and risk of Clostridium difficile infection Mary A M Rogers1*, M Todd Greene1, Vincent B Young1, Sanjay Saint1,2, Kenneth M … Continue reading →
Neuroprotective properties of magnesium infusion during carotid endarterectomy, and beyond?
Went to a masterful talk by E. Sander Connolly at the Lenox Hill Hospital neurology conference last week. This is one of many interesting take-away points. Differential blood-brain barrier penetration by the various statins is another one – currently looking … Continue reading →
Ben Goldacre: What doctors don’t know about the drugs they prescribe | Video on TED.com
Ben Goldacre: What doctors don’t know about the drugs they prescribe | Video on TED.com Continue reading →
Modifiable factors influencing relapses and disability in multiple sclerosis.
Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18. Modifiable factors influencing relapses and disability in multiple sclerosis. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Source National Center For Multiple Sclerosis, Melsbroek, Belgium. marie.dhooghe@ms-centrum.be Abstract A growing … Continue reading →
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?
Fingolimod treatment for multiple sclerosis patie… [Ann Neurol. 2011] – PubMed – NCBI. Ann Neurol. 2011 Oct;70(4):673-4; author reply 674. doi: 10.1002/ana.22605. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A, Loebermann M, Reisinger EC, … Continue reading →
